Preventing cardiovascular disease in type 2 diabetes: where do things stand with glycemic control? Part two

scientific article published on 01 February 2009

Preventing cardiovascular disease in type 2 diabetes: where do things stand with glycemic control? Part two is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023671124
P356DOI10.1007/S11892-009-0003-Z
P698PubMed publication ID19192418

P2093author name stringAlan Chait
P2860cites workIntensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesQ22250887
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
Effects of intensive glucose lowering in type 2 diabetesQ29547736
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trialsQ34601330
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesionsQ37486465
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysisQ46810855
P433issue1
P921main subjectcardiovascular diseaseQ389735
type 2 diabetesQ3025883
P304page(s)9-10
P577publication date2009-02-01
P1433published inCurrent diabetes reportQ26841965
P1476titlePreventing cardiovascular disease in type 2 diabetes: where do things stand with glycemic control? Part two
P478volume9

Search more.